Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-046369

EVP, Research & CSO sold 7,900 shares at $51.08 ($403,563)

  • EVP, Research & CSO acquired 7,900 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Virgin Herbert · EVP, Research & CSO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-08-11 Exercise or conversion : show line 1 in the form +7,900 $1.53 $12,087 7,900 D
2020-08-11 Sale : show line 2 in the form −7,900 $51.08 $403,563 0 D
Open-market sales · 7,900 sh · avg $51.08 · $403,563

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-08-11 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −7,900 500,255 D
Loading xslF345X03/doc4.xml…